Crossmark

Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Latin America: report from an antimicrobial surveillance program (2013–2015)

Crossref DOI link: https://doi.org/10.1016/j.bjid.2017.06.008

Published Print: 2017-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Pfaller, Michael A.

Shortridge, Dee

Sader, Helio S.

Gales, Ana

Castanheira, Mariana

Flamm, Robert K.
Funding

Funding for this research was provided by:

Merck & Co., Inc.
License Information

Text and Data Mining valid from 2017-11-01

Version of Record valid from 2017-05-10
More Information

This article is maintained by: Elsevier

Article Title: Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Latin America: report from an antimicrobial surveillance program (2013–2015)

Journal Title: The Brazilian Journal of Infectious Diseases

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.bjid.2017.06.008

Content Type: article

Copyright: © 2017 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda.

Document is current

Any future updates will be listed below